Cargando…
Glucocorticoid therapy reduces ocular hypertension in active moderate-severe thyroid-associated orbitopathy
PURPOSE: Ocular hypertension (OHT) is an important clinical feature of thyroid-associated orbitopathy (TAO).While the prevalence and outcome of OHT in TAO remains unclear. This study investigates this in moderate-severe active TAO. METHODS: Sixty-eight patients with active moderate-severe TAO were r...
Autores principales: | Tang, Chengyang, liang, Liang, zheng, Xiaoya, Hu, Hong, Liu, Chun, Long, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503215/ https://www.ncbi.nlm.nih.gov/pubmed/36151558 http://dx.doi.org/10.1186/s12902-022-01153-w |
Ejemplares similares
-
Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves’ orbitopathy
por: Shen, Liyun, et al.
Publicado: (2022) -
Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy
por: Lin, Miaoli, et al.
Publicado: (2015) -
Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves’ orbitopathy
por: Park, Jungyul, et al.
Publicado: (2023) -
Thyroid associated orbitopathy
por: Maheshwari, Rajat, et al.
Publicado: (2012) -
Role of teprotumumab in the treatment of active moderate-to-severe Graves’ orbitopathy
por: Bartalena, Luigi
Publicado: (2022)